Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · Amanita muscaria

Is Amanita muscaria legal in Jamaica?

Confirmed against a primary sourceVerified September 21, 2026
Legal status
No current named entry for Amanita muscaria was proved in the Dangerous Drugs Act. The searches recorded for this row ran «amanita muscaria; muscimol; ácido iboténico», «amanita-muscaria», spelling variants and the chemical name across the consolidated text and returned no named entry and no closed group rule. Section 10(1) is the operative list of drugs to which Part IV applies and it names only medicinal opium, any extract or tincture of the plant cannabis sativa, morphine and its salts, diacetylmorphine and the other esters of morphine, cocaine and ecgonine with their salts and esters, the dihydrocodeinone and morphine N oxide group, and thebaine with the ethers of morphine; Part IIIA reaches ganja alone, defined in section 2 by reference to the plant and its resin. The row separates the mushroom from its muscimol and ibotenic-acid constituents. There is no First Schedule of substances in this Act to consult: the Schedule it carries is the set of licence Forms A, B and D. Section 11(2) and 11(3) let the Minister extend Part IV by order, and orders of that kind are published as separate Legal Notices which this consolidation does not reproduce, so absence from section 10 is not a finding that this substance is uncontrolled in Jamaica.
Consequences if caught
Capital exposure: none. The words death, capital and hanging appear nowhere in the 43 page consolidated Dangerous Drugs Act, and every penalty limb in it stops at imprisonment: thirty five years on conviction before a Circuit Court under sections 7B, 8A and 8B, and five years or less on summary conviction before a Resident Magistrate. No penalty limb is assigned to this row, because no placement was proved and a ceiling copied across from a neighbouring row would be an invention. The searches recorded were «amanita muscaria; muscimol; ácido iboténico», «amanita-muscaria», spelling variants and the chemical name, and the row separates the mushroom from its muscimol and ibotenic-acid constituents. If an identification or a Ministerial order under section 11 were to bring the material within Part IV, sections 8A and 8B would carry the thirty five year Circuit Court ceiling and the summary alternative of a fine not exceeding five hundred thousand dollars or five years. If it were identified as ganja or its resin, the ounce based scale in sections 7B and 7C would apply instead. Neither of those is asserted here.
If prescribed or medical
This is plant or preparation material rather than a dispensed medicine, so a foreign prescription is unlikely to exist for it and would not in any event be a Jamaican authorisation. No schedule placement attaches to this row on the face of this instrument, so nothing in the Act tells a traveller which authorisation, if any, would be the right one to hold. Section 15 requires a dangerous drug brought to the Island in transit to be accompanied by a valid and subsisting export authorization or diversion certificate. The term recorded for this row in the compilation is «amanita muscaria; muscimol; ácido iboténico», and the identification question that has to be settled before any authorisation answer is given is the one this row was drawn around, which separates the mushroom from its muscimol and ibotenic-acid constituents.
Documentation
Do not read the absence of an entry as permission. Ask the Ministry of Justice or the nearest Jamaican mission whether a Ministerial order under section 11, or any medicines or pharmacy instrument outside this Act, reaches this substance, and ask before travelling rather than on arrival. If you carry it as a medicine, bring the original packaging, the prescription and a letter naming the patient, the active ingredient, the dose and the treatment period. When you confirm this row, ask the question it turns on, namely whether the answer separates the mushroom from its muscimol and ibotenic-acid constituents. The searches relied on here, «amanita muscaria; muscimol; ácido iboténico», «amanita-muscaria», spelling variants and the chemical name, were read on 20 September 2026.
Primary sources
  • Jamaica, the Dangerous Drugs Act, consolidated text, sections 10, 11 and 22, read at https://laws.moj.gov.jm/library/statute/the-dangerous-drugs-act/download, the Ministry of Justice laws of Jamaica library
  • the download is a 43 page scan of the consolidation whose latest amendment notes are L.N. 3/2001 and, on the Part IIIA pages, L.N. 192A/2017, and five of its pages carry no text layer and were read as page images. This citation is document level and not per substance: the links column of the compilation for this row holds the constructed text «amanita-muscaria schedule | amanita-muscaria penalty» rather than an address, and the single hyperlink target in the whole document is the download named above, so no per row source exists and none is implied. The compilation's own outcome for this row is not verified, and the terms it records as searched are «amanita muscaria
  • muscimol
  • ácido iboténico», «amanita-muscaria», spelling variants and the chemical name. There is no First Schedule of substances in this Act
  • its Schedule is the set of licence Forms A, B and D, and the list of drugs to which Part IV applies is in section 10(1). The row boundary the read was carried out against is recorded as follows: it separates the mushroom from its muscimol and ibotenic-acid constituents. Read as at 20 September 2026.

Court records

We have not yet assessed whether court records are publicly available for this jurisdiction.

Amanita muscaria in related jurisdictions

Other substances confirmed in Jamaica